Related Experiment Video
Updated: Sep 2, 2025

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
Published on: April 3, 2021
Exon skipping in genes encoding lineage-defining myogenic transcription factors in rhabdomyosarcoma
Erin Butler1, Lin Xu2, Dinesh Rakheja2
1University of Texas Southwestern Medical Center; erin.butler@utsouthwestern.edu.
Abstract:
Rhabdomyosarcoma (RMS) is a childhood sarcoma composed of myoblast-like cells, which suggests a defect in terminal skeletal muscle differentiation. To explore potential defects in the differentiation program, we searched for mRNA splicing variants in genes encoding transcription factors driving skeletal muscle lineage commitment and differentiation. We studied two RMS cases and identified altered splicing resulting in "skipping" the second of three exons in MYOD1. RNA-Seq data from 42 tumors and additional RMS cell lines revealed exon 2 skipping in both MYOD1 and MYF5 but not in MYF6 or MYOG. Complementary molecular analysis of MYOD1 mRNA found evidence for exon skipping in 5 additional RMS cases. Functional studies showed that so-called MYODΔEx2 protein failed to robustly induce muscle-specific genes, and its ectopic expression conferred a selective advantage in cultured fibroblasts and an RMS xenograft. In summary, we present previously unrecognized exon skipping within MYOD1 and MYF5 in RMS, and we propose that alternative splicing can represent a mechanism to alter the function of these two transcription factors in RMS.
Insights
Researchers found new alternative splicing in MYOD1 and MYF5 genes in rhabdomyosarcoma (RMS), a childhood cancer. This altered splicing disrupts muscle cell differentiation, potentially contributing to RMS development.
Area of Science:
- Molecular Biology
- Cancer Research
- Developmental Biology
Background:
- Rhabdomyosarcoma (RMS) is a pediatric cancer characterized by immature muscle cells, indicating a failure in skeletal muscle differentiation.
- Transcription factors are crucial for skeletal muscle lineage commitment and differentiation.
Purpose of the Study:
- To investigate potential defects in the differentiation program of RMS by searching for mRNA splicing variants in key muscle development transcription factors.
- To identify alternative splicing events in MYOD1 and MYF5 genes in RMS tumors.
Main Methods:
- Analysis of mRNA splicing variants in RMS tumor samples and cell lines using RNA-sequencing.
- Complementary molecular analysis of MYOD1 mRNA.
- Functional studies of the resulting MYOD1 variant protein (MYODΔEx2).
Main Results:
- Identified exon 2 skipping in MYOD1 and MYF5 genes in RMS, but not in MYF6 or MYOG.
- Confirmed exon skipping in MYOD1 in additional RMS cases.
- Demonstrated that the MYODΔEx2 protein is less effective at inducing muscle-specific genes and confers a growth advantage in non-muscle cells and RMS xenografts.
Conclusions:
- Alternative splicing, specifically exon skipping in MYOD1 and MYF5, is a previously unrecognized mechanism contributing to altered transcription factor function in RMS.
- These splicing alterations may play a role in the pathogenesis of rhabdomyosarcoma by impairing terminal muscle differentiation.
Related Concept Videos
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
RNA Splicing
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Induced Pluripotent Stem Cells
Somatic...
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...

